S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Federal student loan payments are starting again. Here's what you need to know
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Federal student loan payments are starting again. Here's what you need to know
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Federal student loan payments are starting again. Here's what you need to know
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Federal student loan payments are starting again. Here's what you need to know
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
NASDAQ:BIOL

BIOLASE (BIOL) Earnings Date, Estimates & Call Transcripts

$1.86
+0.06 (+3.33%)
(As of 09/29/2023 ET)
Compare
Today's Range
$1.70
$1.91
50-Day Range
$1.59
$675.00
52-Week Range
$1.56
$258.00
Volume
168,140 shs
Average Volume
454,767 shs
Market Capitalization
$1.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$513.50

Earnings Summary

Upcoming
Earnings Date
Nov. 9Estimated
Actual EPS
(Aug. 10)
-$8.93 Missed By -$8.93
Skip Charts & View Estimated and Actual Earnings Data

BIOL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIOL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BIOL Earnings Date and Information

BIOLASE last issued its quarterly earnings data on August 10th, 2023. The medical technology company reported ($8.93) EPS for the quarter. The company earned $14.29 million during the quarter. BIOLASE has generated ($264.93) earnings per share over the last year (($264.93) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off prior year's report dates.

BIOLASE Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2023
Estimated)
------- 
8/10/2023Q2 2023-($8.93)($8.93)($8.93)-$14.29 million
5/11/2023Q1 2023-($18.00)($18.00)($0.18)-$10.47 million
3/28/2023Q4 2022-($128.00)($128.00)($1.28)-$14.05 million
11/10/2022Q3 2022-($110.00)($110.00)($1.10)-$12.01 million
8/11/2022Q2 2022-($91.00)($91.00)($0.91)-$12.24 million    
5/12/2022Q1 2022-($81.00)($81.00)($0.81)-$10.17 million
3/17/2022Q4 2021($75.00)($75.00)-($0.03)-$12.41 million    
11/10/2021Q3 2021($75.00)($50.00)+$25.00($0.02)-$9.53 million    
8/11/2021Q2 2021($100.00)($50.00)+$50.00($0.04)-$9.13 million    
5/13/2021Q1 2021($125.00)($150.00)($25.00)($0.06)-$8.12 million  
3/24/2021Q4 2020($100.00)($175.00)($75.00)($0.07)-$8.52 million  
11/17/2020Q3 2020($125.00)($525.00)($400.00)($0.21)-$6.54 million  












BIOLASE Earnings - Frequently Asked Questions

When is BIOLASE's earnings date?

BIOLASE has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off last year's report dates. Learn more on BIOL's earnings history.

How much revenue does BIOLASE generate each year?

BIOLASE (NASDAQ:BIOL) has a recorded annual revenue of $48.46 million.

How much profit does BIOLASE generate each year?

BIOLASE (NASDAQ:BIOL) has a recorded net income of -$28.63 million. BIOL has generated -$264.93 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:BIOL) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -